Skip to content

AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL

AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01278420
Enrollment
60
Registered
2011-01-17
Start date
2010-09-30
Completion date
2012-12-31
Last updated
2012-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery

Brief summary

The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.

Detailed description

The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.

Interventions

DEVICETecnis MF

30 subjects will be implanted with the Tecnis MF

DEVICEReSTOR

30 subjects will be implanted with ReSTOR

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 or greater * Bilateral condition (cataracts or Presbyopia) for which phacoemulsification and posterior IOL implantation has been planned for both eyes * Visual potential of 20/25 or better in each eye after cataract removal and IOL implantation * Clear intraocular media other than cataract * Normal OCT of the macula * No evidence of Keratoconus or significant irregular astigmatism on Preoperative topography * No evidence of Epithelial Basement Membrane Dystrophy on Slit lamp Exam * Availability, willingness, and sufficient cognitive awareness to comply with examination procedures

Exclusion criteria

* Use of systemic or ocular medications that may affect vision * Uncontrolled systemic or ocular disease * History of ocular trauma * History of intraocular, extraocular Muscle, or corneal surgery (including laser vision correction) * Amblyopia or strabismus * Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.) * Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal disorders) that are predicted to cause future acuity losses to a level of 20/25 or worse * Subjects who may be expected to require retinal laser treatment or other surgical intervention (i.e patients with diabetic retinopathy) * Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome) * Contact lens usage within 2 months for PMMA contacts lenses, 2 weeks for gas permeable lenses or 3 days for extended-wear and daily-wear soft contact lenses

Design outcomes

Primary

MeasureTime frame
Refraction1 year
Distance Visual Acuities1 year
Near Visual Acuities1 year
Intermediate Acuities1 year

Countries

United States

Contacts

Primary ContactJenna Piel
j.piel@imedsonline.com951-653-5566

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026